Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
ID: 349480Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $275K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/349480

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-239.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity titled "Social Disconnection and Suicide Risk in Late Life" (R21 Clinical Trial Optional) aimed at fostering research on the relationship between social disconnection and suicidal thoughts among older adults. This initiative encourages researchers to investigate neurobiological, behavioral, and environmental mechanisms that contribute to suicide risk and resilience, with a focus on health equity and disparities. The funding supports exploratory projects without preliminary data, offering up to $275,000 over two years, with applications due by September 7, 2026. Interested applicants from eligible organizations can find more information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-239-Full-Announcement.html
    PAR-23-239.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has issued a Notice of Funding Opportunity (NOFO) titled "Social Disconnection and Suicide Risk in Late Life" (R21 Clinical Trial Optional), designed to spur research into the correlation between social disconnection and suicidal thoughts in older adults. Researchers are encouraged to explore mechanisms at various analytical levels—neurobiological, behavioral, and environmental—that affect suicide risk and resilience while considering health equity and disparities. The funding supports exploratory projects that lack preliminary data, with a budget of up to $275,000 over two years. Applicants must come from eligible organizations, including educational institutions, nonprofits, and government entities, and they need to complete various registrations before applying. The application process requires detailed design plans, adherence to rigorous ethical standards for research with human subjects, and a commitment to share research data post-study. Key deadlines include submission dates starting September 16, 2023, with awards expected to begin after thorough peer review. This initiative addresses rising suicide rates among older populations and the urgent need for effective interventions that leverage social connectivity for mental health support.
    Similar Opportunities
    Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Social Disconnection and Suicide Risk in Late Life," aimed at exploring the relationship between social isolation and suicide risk among older adults. This initiative encourages research projects that investigate neurobiological and environmental mechanisms linking social disconnection and loneliness to increased suicidal thoughts and behaviors, with a focus on developing interventions to enhance social connections and prevent suicide in late life. Given the rising suicide rates in this demographic, the NIH emphasizes the urgent need for targeted research, particularly addressing disparities across various populations. Selected projects may receive funding of up to $275,000 over two years, with applications accepted starting January 2025 and a submission deadline of September 7, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-066.html.
    Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research projects focused on "Social Disconnection and Suicide Risk in Late Life," aimed at understanding the relationship between social isolation and suicidal behaviors among older adults. The initiative encourages applications that explore neurobiological, behavioral, and environmental factors contributing to this issue, with an emphasis on developing interventions to prevent late-life suicide. This funding reflects a critical need for evidence-based strategies to address the rising rates of suicide in older populations, considering health equity and disparities in access to care. Interested applicants can find more information and submit proposals by the deadline of September 7, 2026, and should direct inquiries to grantsinfo@nih.gov.
    Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)" aimed at stimulating research on the relationship between social disconnection, including both objective social isolation and perceived loneliness, and suicide risk among older adults. The initiative seeks applications for research projects that explore neurobiological and environmental mechanisms contributing to suicidal thoughts and behaviors in late life, with a focus on developing and testing interventions to enhance social connection and prevent suicide. This funding opportunity is particularly significant given the rising suicide rates in the aging population, exacerbated by social isolation, and encourages innovative research methodologies to address these mental health challenges. Interested applicants can find more details and submit their proposals by the closing date of September 7, 2026, and should direct inquiries to grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-238.html.
    Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Schizophrenia and Related Disorders During Mid- to Late-Life" (PAR-24-026), aimed at advancing research on the onset and progression of schizophrenia and related disorders in individuals aged 35 and older. This initiative seeks to promote high-risk exploratory and developmental projects that investigate neurobiological, psychosocial, and environmental factors contributing to these disorders, with a particular emphasis on addressing health disparities among minority and aging populations. The program offers a maximum funding amount of $275,000 over two years, with applications due by November 16, 2023, for the initial cycle. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for exploratory research on schizophrenia and related disorders in individuals aged 35 and older, through the R21 grant mechanism. This initiative aims to enhance understanding of the onset, trajectory, and outcomes of these disorders in mid- to late-life, encouraging innovative studies that identify biological, behavioral, and environmental risk factors, as well as potential interventions. The funding, which can reach up to $275,000 over a maximum of two years, is crucial for addressing health disparities faced by older adults with these disorders and promoting novel solutions for their care. Applications are due between January 2025 and October 2026, and interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)" aimed at advancing research on schizophrenia and related disorders in individuals aged 35 and older. This initiative seeks to explore the mechanisms, trajectories, and outcomes of these disorders, with a focus on identifying targets for prevention and treatment interventions, particularly emphasizing the inclusion of diverse research teams and individuals with lived experience. The funding is available through the R01 grant mechanism, with applications due by September 7, 2026, and interested applicants are encouraged to adhere strictly to the application guidelines and contribute data to the National Institute of Mental Health Data Archive. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-023.html.
    Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Schizophrenia and Related Disorders During Mid- to Late-Life," aimed at advancing research on the emergence and trajectory of schizophrenia and related disorders in individuals aged 35 and older. This initiative seeks to identify biological, psychosocial, and environmental mechanisms affecting this population to develop effective prevention and treatment strategies, addressing a critical gap in mental health research. The funding utilizes the R01 grant mechanism, with applications accepted starting January 5, 2025, and a project period of up to five years. Eligible applicants include a wide range of institutions and organizations, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov. The application deadline is September 7, 2026.
    Research Opportunities in Crisis Response Services for Suicide Prevention
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce a funding opportunity for research focused on crisis response services aimed at suicide prevention. This initiative seeks to examine the effectiveness and implementation of crisis response practices, with an emphasis on improving the quality and outcomes of interventions in real-world settings, while considering various psychosocial factors and health disparities. The total estimated funding for this program is $2 million, with approximately five awards expected to be granted. Interested applicants, particularly small businesses with expertise in crisis response and suicide prevention, are encouraged to prepare for this opportunity, with the anticipated synopsis posting date on September 8, 2025, and a closing date for applications on October 8, 2025. For further inquiries, potential applicants can contact Dr. Jennifer Humensky at jennifer.humensky@nih.gov or by phone at 301-480-1265.
    Pilot Effectiveness Trials of Peer Support Services for Suicide Prevention
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "Pilot Effectiveness Trials of Peer Support Services for Suicide Prevention," aimed at soliciting research applications focused on the preliminary effectiveness of peer support interventions in reducing suicide risk. The initiative seeks to evaluate the feasibility, acceptability, and potential effectiveness of these interventions in clinical and community settings, while also gathering preliminary data necessary for larger-scale trials. This grant, categorized under health funding activities, has an estimated total program funding of $3 million and is open to small businesses with relevant expertise. Interested applicants should note that applications are not currently being solicited, but they are encouraged to prepare collaborative projects ahead of the estimated synopsis posting on August 28, 2025, with a closing date for submissions anticipated on October 28, 2025. For further inquiries, potential applicants can contact Stephen O'Connor, Ph.D., at stephen.oconnor@nih.gov or by phone at 301-480-8366.
    Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia," aimed at enhancing the understanding of neuropsychiatric symptoms associated with Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD). This initiative invites exploratory research to identify the neurobiological and behavioral pathways that contribute to symptoms such as aggression, depression, anxiety, and agitation, with the goal of discovering novel therapeutic approaches for treatment. The funding, available through the R21 grant mechanism, supports diverse methodologies and interdisciplinary collaboration, with a maximum budget of $275,000 over two years. Applications are due by September 7, 2026, and eligible applicants include a wide range of institutions and organizations, including educational institutions, non-profits, and foreign entities. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.